The Bridge

Get the latest insights on provider-supplier collaboration

The most promising COVID-19 drugs in development—and 3 questions to ask going forward

by Brandi Greenberg, Managing Director and Pam Divack, Senior Analyst, Life Sciences Research March 24, 2020

Pharmaceutical companies are racing to find vaccines, treatments, and cures for the new coronavirus by researching new-in-kind compounds and testing compounds that have already been assessed—and in some cases approved—to treat other existing conditions.

Read more »

How Philips IGT and Holston Valley overcame 3 common risk-share challenges

by Jessie Goldman November 4, 2019

In Part 1 of this two-part series on provider-supplier risk-sharing, we recapped the state of risk-sharing in 2019. If you missed it, here's the gist: Most providers are interested in these agreements because they push suppliers to take on more cost-quality performance risk and are an opportunity to improve clinical quality. Still, the pickup for these agreements has been slow as parties have been stymied by some formidable obstacles. More specifically, providers point to the challenges inherent in selecting metrics that are both measurable and meaningful, investing in requisite data extraction and analysis capabilities, and brokering a long-term partnership whose benefits are uncertain from the outset.

Read more »

71% of providers are interested in risk-based deals with suppliers—so why are they still so rare?

by Jessie Goldman October 21, 2019

Last year, we offered our take on why risk-share agreements, also commonly called outcomes-based contracts, are proposed far more frequently than they are executed. We recently re-surveyed health system supply chain leaders on the topic and found that many of the challenges we highlighted 18 months ago are still top of mind for two reasons:

Read more »

What is 'value,' anyway? Help us find out.

by Pam Divack August 26, 2019

Value-based care. Fee-for-value. Value-based contracts.

"Value" may be the most overused word in our health care lexicon today, but none of us agree on what it means. We still don't have a common definition or shared framework for truly assessing medical value in U.S. health care.

Read more »

3 ways providers are boosting their revenue—beyond care delivery

by Nicholas Hula and Lindsay Conway July 8, 2019

To remain financially stable and strategically flexible, hospitals need to grow revenue while also cutting costs. However, revenue growth is becoming more difficult as inpatient volumes decline, outpatient price points remain low, and competition in both spaces gets ever stronger.

Read more »

Your top 4 reimbursement questions, answered

by Viggy Hampton and Lindsay Conway May 6, 2019

With all of the new policies and payment methodologies, it can be easy to get lost in the reimbursement labyrinth. Here, we've answered a few FAQs to help you stay up-to-date on pay-for-performance, bundles, accountable care organizations (ACOs), and telehealth. We've also included additional resources for further learning and offered implications for suppliers and service providers.

Read more »

Rev cycle leaders shared their priorities at our summit. Here's what they told us—and what it means for you.

by Jessie Goldman and Robin Brand April 15, 2019

Under intensifying margin pressures, revenue cycle can no longer be viewed as the cost of doing business; instead, it must be treated as a more strategic asset. For vendors in the space, this approach could mean both good and bad news. More providers may look to third parties for support—but in such a crowded market, providers are struggling to separate signal from noise.

Read more »

A sneak peek into how C-suite priorities will affect your IDN relationships

Miriam Sznycer-Taub December 10, 2018

With so many of our supplier and service provider members in the midst of strategic planning for 2019, we've received a number of questions about the top priorities for health systems moving into next year. Earlier this year our colleagues at the Health Care Advisory Board surveyed nearly 150 C-Suite executives about their top concerns and strategic priorities. The top five areas of concern shared by survey respondents were:

Read more »